A Randomized Phase II Study of Concurrent Chemoradiation With Every 3 Week of Cisplatin vs With Weekly Cisplatin in Locally Advanced Nasopharyngeal Carcinoma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
The study try to show the weekly cisplatin based CCRT is not inferior to 3-weekly cisplabe based CCRT in terms of 3-yr progression free survival rate in advanced nasopharyngeal carcinoma
Epistemonikos ID: 73c608f3ec7162d9aeea2cfdce1aabcf194c17d1
First added on: May 05, 2024